TY - JOUR
T1 - Does transcranial direct current stimulation enhance cognitive performance in Parkinson’s disease mild cognitive impairment? An event-related potentials and neuropsychological assessment study
AU - Aksu, Serkan
AU - Uslu, Atilla
AU - İşçen, Pınar
AU - Tülay, Emine Elif
AU - Barham, Huzeyfe
AU - Soyata, Ahmet Zihni
AU - Demirtas-Tatlidede, Asli
AU - Yıldız, Gülsen Babacan
AU - Bilgiç, Başar
AU - Hanağası, Haşmet
AU - Woods, Adam J.
AU - Karamürsel, Sacit
AU - Uyar, Fatma Aytül
N1 - Publisher Copyright:
© 2022, Fondazione Società Italiana di Neurologia.
PY - 2022/6
Y1 - 2022/6
N2 - Background: Parkinson’s disease-mild cognitive impairment (PD-MCI) is garnering attention as a key interventional period for cognitive impairment. Currently, there are no approved treatments for PD-MCI and encouraging results of transcranial direct current stimulation (tDCS) combined with other interventions have been proposed, though the efficacy and neural mechanisms of tDCS alone have not been studied in PD-MCI yet. Objectives: The present double-blind, randomized, sham-controlled study assessed the effects of tDCS over the dorsolateral prefrontal cortex on cognitive functions via neuropsychological and electrophysiological evaluations in individuals with PD-MCI for the first time. Method: Twenty-six individuals with PD-MCI were administered 10 sessions of active (n = 13) or sham (n = 13) prefrontal tDCS twice a day, for 5 days. Changes were tested through a comprehensive neuropsychological battery and event-related potential recordings, which were performed before, immediately, and 1 month after the administrations. Results: Neuropsychological assessment showed an improvement in delayed recall and executive functions in the active group. N1 amplitudes in response to targets in the oddball test-likely indexing attention and discriminability and NoGo N2 amplitudes in the continuous performance test-likely indexing cognitive control and conflict monitoring increased in the active group. Active stimulation elicited higher benefits 1 month after the administrations. Conclusion: The present findings substantiate the efficacy of tDCS on cognitive control and episodic memory, along with the neural underpinnings of cognitive control, highlighting its potential for therapeutic utility in PD-MCI. Trial registration. NCT 04,171,804. Date of registration: 21/11/2019.
AB - Background: Parkinson’s disease-mild cognitive impairment (PD-MCI) is garnering attention as a key interventional period for cognitive impairment. Currently, there are no approved treatments for PD-MCI and encouraging results of transcranial direct current stimulation (tDCS) combined with other interventions have been proposed, though the efficacy and neural mechanisms of tDCS alone have not been studied in PD-MCI yet. Objectives: The present double-blind, randomized, sham-controlled study assessed the effects of tDCS over the dorsolateral prefrontal cortex on cognitive functions via neuropsychological and electrophysiological evaluations in individuals with PD-MCI for the first time. Method: Twenty-six individuals with PD-MCI were administered 10 sessions of active (n = 13) or sham (n = 13) prefrontal tDCS twice a day, for 5 days. Changes were tested through a comprehensive neuropsychological battery and event-related potential recordings, which were performed before, immediately, and 1 month after the administrations. Results: Neuropsychological assessment showed an improvement in delayed recall and executive functions in the active group. N1 amplitudes in response to targets in the oddball test-likely indexing attention and discriminability and NoGo N2 amplitudes in the continuous performance test-likely indexing cognitive control and conflict monitoring increased in the active group. Active stimulation elicited higher benefits 1 month after the administrations. Conclusion: The present findings substantiate the efficacy of tDCS on cognitive control and episodic memory, along with the neural underpinnings of cognitive control, highlighting its potential for therapeutic utility in PD-MCI. Trial registration. NCT 04,171,804. Date of registration: 21/11/2019.
KW - ERP
KW - Event-related potentials
KW - Mild cognitive impairment
KW - Neuropsychological assessment
KW - Parkinson’s disease
KW - Transcranial direct current stimulation
KW - tDCS
UR - http://www.scopus.com/inward/record.url?scp=85127339834&partnerID=8YFLogxK
U2 - 10.1007/s10072-022-06020-z
DO - 10.1007/s10072-022-06020-z
M3 - Article
C2 - 35322340
AN - SCOPUS:85127339834
SN - 1590-1874
VL - 43
SP - 4029
EP - 4044
JO - Neurological Sciences
JF - Neurological Sciences
IS - 6
ER -